Actualités Eli Lilly and Company - LLY | Actions Toronto Stock Exchange

Votre Hub pour des idées et discussions en direct en temps réel

Exenatide Once Weekly New Drug Application Review Extended By FDA Due to Weather-Related Closure

SAN DIEGO, INDIANAPOLIS and WALTHAM, Mass., Feb. 25, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN), Eli Lilly and...

Lilly's Online, Interactive Health Education Program Receives Two Web Awards

Health Education Answers recognized as an effective online tool by eHealthcare Leadership Awards and Web Marketing Association INDIANAPOLIS, Feb...

Critical Alerts for Berkshire-Hathaway, Philip Morris International, AFLAC, Eli Lilly, and DR Horton Released by Seven Summits R

CHICAGO, Jan. 22 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for BRK.B, PM, AFL, LLY, and DHI. Seven Summits Strategic...

Lilly CEO Stresses Human Element in Driving Medical Innovation

Los Angeles Town Hall Speech Outlines Policies to Advance Medicine in New Decade LOS ANGELES, Jan. 14 /PRNewswire-FirstCall/ -- In the keynote...

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Companies to co-promote newly-approved statin LIVALO in the U.S. market Lilly licenses LIVALO commercialization rights for Latin America...

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Companies to co-promote newly-approved statin LIVALO in the U.S. market Lilly licenses LIVALO commercialization rights for Latin America...

Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance

NEW YORK, Dec. 10 /PRNewswire-FirstCall/ -- -- Company remains focused on speeding innovation to patients and delivering greater value to...

FDA Approves Lilly's Zyprexa for Two Adolescent Indications

INDIANAPOLIS, Dec. 4 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form...

FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder

INDIANAPOLIS, Nov. 30 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the...

Deadline Extended to December 16 to Submit Nominations for Depression Awards Program

Winners Can Receive Up to $15,000 Each to Donate to Nonprofit of Their Choice NEW YORK, Nov. 11 /PRNewswire-FirstCall/ -- The deadline to submit...

Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day

Life for a Child film debuted at Tribeca festival, named Best Documentary Short at Cinequest NEW YORK, Nov. 9 /PRNewswire-FirstCall/ -- The...

Oncology On Canvas(SM) Launches 2010 Art Competition for Individuals Touched by Cancer

Launch Coincides with Free Public Exhibits in Four Cities in November INDIANAPOLIS, Nov. 4 /PRNewswire-FirstCall/ -- "Feel. Create. Share the...

Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation

Lilly Has Biotech Discovery Research and Development Centers on Both Coasts and in the Midwest SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- As...

Lilly Expands Disease Management Program to Reach Growing Asian-American Population

Health Education Answers, an interactive online program, is now available in Mandarin INDIANAPOLIS, Oct. 29 /PRNewswire-FirstCall/ -- To expand...

November is Lung Cancer Month: Know the Latest Information About This Deadliest of Cancers

INDIANAPOLIS, Oct. 27 /PRNewswire-FirstCall/ -- Lung cancer is the world's most common cancer, and an estimated 219,440 Americans are expected...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Eli Lilly and Company (LLY)

Votre Hub pour des idées et discussions en direct en temps réel

Eli Lilly and Company (LLY) Actualités

Exenatide Once Weekly New Drug Application Review Extended By FDA Due to Weather-Related Closure

Lilly's Online, Interactive Health Education Program Receives Two Web Awards

Critical Alerts for Berkshire-Hathaway, Philip Morris International, AFLAC, Eli Lilly, and DR Horton Released by Seven Summits R

Lilly CEO Stresses Human Element in Driving Medical Innovation

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance

FDA Approves Lilly's Zyprexa for Two Adolescent Indications

FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder

Deadline Extended to December 16 to Submit Nominations for Depression Awards Program

Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day

Oncology On Canvas(SM) Launches 2010 Art Competition for Individuals Touched by Cancer

Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation

Lilly Expands Disease Management Program to Reach Growing Asian-American Population

November is Lung Cancer Month: Know the Latest Information About This Deadliest of Cancers

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Eli Lilly and Company (LLY)

Votre Hub pour des idées et discussions en direct en temps réel

Eli Lilly and Company (LLY) Actualités

Exenatide Once Weekly New Drug Application Review Extended By FDA Due to Weather-Related Closure

Lilly's Online, Interactive Health Education Program Receives Two Web Awards

Critical Alerts for Berkshire-Hathaway, Philip Morris International, AFLAC, Eli Lilly, and DR Horton Released by Seven Summits R

Lilly CEO Stresses Human Element in Driving Medical Innovation

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance

FDA Approves Lilly's Zyprexa for Two Adolescent Indications

FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder

Deadline Extended to December 16 to Submit Nominations for Depression Awards Program

Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day

Oncology On Canvas(SM) Launches 2010 Art Competition for Individuals Touched by Cancer

Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation

Lilly Expands Disease Management Program to Reach Growing Asian-American Population

November is Lung Cancer Month: Know the Latest Information About This Deadliest of Cancers

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités